Antimicrobial peptides in the first line defence of human colon mucosa
about
Antimicrobial proteins in intestine and inflammatory bowel diseasesIntestinal barrier in inflammatory bowel diseaseLactose in human breast milk an inducer of innate immunity with implications for a role in intestinal homeostasisMacrophage autophagy in immunity to Cryptococcus neoformans and Candida albicans.Molecular cloning of cecropin B responsive endonucleases in Yersinia ruckeri.Circulating cathelicidin levels correlate with mucosal disease activity in ulcerative colitis, risk of intestinal stricture in Crohn's disease, and clinical prognosis in inflammatory bowel disease.Association between preoperative 25-hydroxyvitamin D level and hospital-acquired infections following Roux-en-Y gastric bypass surgeryBacteroides fragilis enterotoxin induces human beta-defensin-2 expression in intestinal epithelial cells via a mitogen-activated protein kinase/I kappaB kinase/NF-kappaB-dependent pathway.Peptide-based Antifungal Therapies against Emerging Infections.Inflammatory bowel disease: an impaired barrier disease.Whipple's disease: a macrophage diseaseEndogenous cathelicidin production limits inflammation and protective immunity to Mycobacterium avium in mice.The front line of enteric host defense against unwelcome intrusion of harmful microorganisms: mucins, antimicrobial peptides, and microbiotaGastric antimicrobial peptides fail to eradicate Helicobacter pylori infection due to selective induction and resistanceVitamin D status and community-acquired pneumonia: results from the third National Health and Nutrition Examination SurveyVitamin D status and acute respiratory infection: cross sectional results from the United States National Health and Nutrition Examination Survey, 2001-2006.Association between prehospital vitamin D status and hospital-acquired Clostridium difficile infections.Cationic antimicrobial peptides - an update.Effects of vitamin D supplementation on intestinal permeability, cathelicidin and disease markers in Crohn's disease: Results from a randomised double-blind placebo-controlled study.Reduced mucosal antimicrobial activity in Crohn's disease of the colon.Effect of Cholecalciferol Supplementation on Vitamin D Status and Cathelicidin Levels in Sepsis: A Randomized, Placebo-Controlled Trial.Defensin deficiency, intestinal microbes, and the clinical phenotypes of Crohn's disease.Transcriptome Dynamics and Potential Roles of Sox6 in the Postnatal Heart.Association of Vitamin D Status and Acute Rhinosinusitis: Results From the United States National Health and Nutrition Examination Survey 2001-2006.Ubiquitously expressed Human Beta Defensin 1 (hBD1) forms bacteria-entrapping nets in a redox dependent mode of actionHistological and MS spectrometric analyses of the modified tissue of bulgy form tadpoles induced by salamander predationToll-like receptors and their role in periodontal health and disease.Defensins and Paneth cells in inflammatory bowel disease.The Clostridium difficile Dlt Pathway Is Controlled by the Extracytoplasmic Function Sigma Factor σV in Response to Lysozyme.Addition of 25-hydroxyvitamin D levels to the Deyo-Charlson Comorbidity Index improves 90-day mortality prediction in critically ill patients.Cell-mediated reduction of human β-defensin 1: a major role for mucosal thioredoxinOn the physiology and pathophysiology of antimicrobial peptides.Innate immunity in the human female reproductive tract: endocrine regulation of endogenous antimicrobial protection against HIV and other sexually transmitted infections.Innate antimicrobial immunity in inflammatory bowel diseases.Intestinal epithelial cells and their role in innate mucosal immunityHost defense peptides: general overview and an update on their activity against Chlamydia spp.α-Defensins in human innate immunity.Optimal vitamin D levels in Crohn's disease: a review.Functional synergy between antimicrobial peptoids and peptides against Gram-negative bacteriaVit D deficiency is a possible risk factor in ARS.
P2860
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
P248
Q27023239-52879681-7C8E-4856-9B58-39D4BC6D5403Q27023724-8D6ED421-C986-4235-BC9C-3E704BDE15E2Q28484943-ACFA5D58-C0C4-478E-80DE-1BB2C88C0A34Q28588761-E6963706-FA72-4B39-A747-422673466DD1Q33547486-9E67D46E-0CB7-4DE7-9CC6-B10F8599F04DQ33667766-B2C18E29-749C-4847-8F30-11989515B164Q33775588-1DDB5D0C-2E0A-4DF8-976C-EFD4E0B54F14Q33826157-F7500D11-D9E1-4431-B207-E5D20B65902EQ33862289-82D84F3F-F337-496A-8D3E-9B98791940ADQ34312402-A12439DA-BFFD-4EC4-AE01-02F516382ACBQ34429342-A1D9CE93-F337-438C-A1D0-166E8358D91DQ34454677-5018FFC9-89C2-4C1D-92E4-6F89117AA51EQ34647328-B541AEA9-3917-4B00-94B7-2D8EB492EAD5Q34989437-A5C6D410-1D90-4273-93DF-CEBDD1A909B7Q35049459-28803893-BEA4-45B7-BC4E-3BC61469B411Q35227910-6449E27A-6F73-4703-9C2E-C6369DC16098Q35472719-2B7C1F07-B1B8-404D-957A-7CD9C8AF9A4AQ35680641-8DA5C9B3-668E-41BF-8205-CBE495AA90F7Q35780832-4110B9A5-3497-4961-AF4C-2E5A374860FFQ35954105-5ECDBBC3-CA47-4E0C-89DA-9A37701CF696Q35957492-8B5BD2BE-CB07-4191-8DA8-B9F334AEBD9FQ35993236-FA3867A6-DEA7-4C68-B8E9-40EC1D8D00D1Q36188897-C1668DE3-D1DD-4C31-B1DC-86BE892FBECCQ36195429-922E5010-F1F8-4974-B0AD-FC12465506F5Q36316530-19957F7D-3F3C-4575-AD76-CEE591BDE5BFQ36432062-E3B0A65A-95C6-45E6-8D18-BA7B12852314Q36703941-0676B6A8-F464-4654-AB1F-99451F8EBEADQ36849133-3744EAEE-C974-4E06-A0A6-B3FFFC04BB19Q37002320-6E92457A-85D3-43D9-A465-9387CA87BB63Q37018179-9AE8C80F-0663-4F1C-A132-1AC9A46C5F04Q37250664-7974A369-D4A5-4D1D-81CB-E2BBC37DD3D3Q37327972-79AA4411-B246-44ED-AA03-BA872F944582Q37334286-EE6ACBCE-C0CF-4154-9F66-617B1FBB43E9Q37786633-33CA7A76-3E18-4855-BAF1-BB99D02FDAA6Q37811994-4E335305-766E-4A68-B3C1-FBA608DA2EDBQ37845727-A2E64CE7-E6C3-468E-B164-46FA2FCCA9AEQ37968296-B8652DE6-4E4F-40B5-A87D-44E307FE37C3Q38286526-89459CBD-4801-4627-A756-EC23F733753FQ38726022-712CE3B1-FA0D-41DE-B900-F7D23E2284C9Q38728398-5989084C-865D-4CC8-A108-4A92BE5BF1A0
P2860
Antimicrobial peptides in the first line defence of human colon mucosa
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Antimicrobial peptides in the first line defence of human colon mucosa
@ast
Antimicrobial peptides in the first line defence of human colon mucosa
@en
Antimicrobial peptides in the first line defence of human colon mucosa
@en-gb
Antimicrobial peptides in the first line defence of human colon mucosa
@nl
type
label
Antimicrobial peptides in the first line defence of human colon mucosa
@ast
Antimicrobial peptides in the first line defence of human colon mucosa
@en
Antimicrobial peptides in the first line defence of human colon mucosa
@en-gb
Antimicrobial peptides in the first line defence of human colon mucosa
@nl
prefLabel
Antimicrobial peptides in the first line defence of human colon mucosa
@ast
Antimicrobial peptides in the first line defence of human colon mucosa
@en
Antimicrobial peptides in the first line defence of human colon mucosa
@en-gb
Antimicrobial peptides in the first line defence of human colon mucosa
@nl
P2093
P921
P3181
P1433
P1476
Antimicrobial peptides in the first line defence of human colon mucosa
@en
P2093
Hans Jörnvall
Maria Tollin
Peter Bergman
Torgny Svenberg
P304
P3181
P356
10.1016/S0196-9781(03)00114-1
P407
P577
2003-04-01T00:00:00Z